ABEV
Ambev SA ADR
Ambev SA ADR historical holders
total: 6
Oaktree Capital Management Ambev SA ADR transactions over time
- Total transactions:
- 13
- New positions:
- 2
- Sold out:
- 2
- Added:
- 8
- Reduced:
- 1
- Held since:
- 2016 Q2
- Held for:
- 8 quarters
- Latest activity:
- 2018 Q2
Howard Marks has been an institutional investor in Ambev SA ADR (ABEV) since 2013 Q4. According to 2026 Q1 report, Howard Marks doesn't hold any shares. The fund/company first acquired ABEV in 2013 Q4, initially purchasing about 2.01M shares. Howard Marks later completely sold out the position and reinvested in ABEV again in 2016 Q2. Since the initial investment, Oaktree Capital Management has made 12 more transactions in this position.
When did Howard Marks exit their ABEV position?
Howard Marks no longer holds Ambev SA ADR (ABEV). They sold off their entire position in 2018 Q2, closing out an investment that began in 2013 Q4.
When did Howard Marks first invest in ABEV?
Howard Marks first invested in Ambev SA ADR (ABEV) in 2013 Q4 at the reported quarter-end price of $7.35 per share, acquiring 2,005,765 shares in their initial purchase.
What is Howard Marks's average cost basis for ABEV?
Based on historical transaction data, Howard Marks's estimated cost basis for Ambev SA ADR (ABEV) is approximately $5.31 per share. This represents their average reported price* across all buy transactions.
Has Howard Marks reinvested in ABEV after selling?
Yes, Howard Marks has shown renewed interest in Ambev SA ADR (ABEV). After completely selling their position, they reinitiated an investment in 2016 Q2, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $5.31
- Weighted AVG sell price:
- $7.11
ABEV transactions history by Oaktree Capital Management
13 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2018 Q2
|
0.00%
|
$7.27
|
-100% (-5,643,716)
|
|||
|
2018 Q1
|
0.66%
|
$7.27
|
+2.46% (+135,675)
|
|||
|
2017 Q4
|
0.57%
|
$6.46
|
+0.75% (+41,256)
|
|||
|
2017 Q3
|
0.54%
|
$6.59
|
+5.22% (+271,009)
|
|||
|
2017 Q2
|
0.47%
|
$5.49
|
+0.75% (+38,476)
|
|||
|
2017 Q1
|
0.46%
|
$5.76
|
+13.50% (+613,537)
|
|||
|
2016 Q4
|
0.34%
|
$4.91
|
+21.88% (+815,805)
|
|||
|
2016 Q3
|
0.32%
|
$6.09
|
-19.62% (-910,242)
|
|||
|
2016 Q2
|
0.43%
|
$5.18
|
new
|
|||
|
2014 Q3
|
0.00%
|
$7.04
|
-100% (-3,395,805)
|
|||
|
2014 Q2
|
0.42%
|
$7.04
|
+28.14% (+745,800)
|
|||
|
2014 Q1
|
0.37%
|
$7.41
|
+32.12% (+644,240)
|
|||
|
2013 Q4
|
0.27%
|
$7.35
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.